| Line item | 2025-11-30 FY | 2024-11-30 FY | 2023-11-30 FY | 2022-11-30 FY | 2021-11-30 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | – | – | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $47.29M | $37.86M | $40.31M | $48.27M | $36.84M |
| R&D | – | – | – | – | – |
| SG&A | $25.38M | $24.94M | $21.78M | $20.11M | $20.21M |
| Operating Income | -$47.29M | -$37.86M | -$40.31M | -$48.27M | -$36.84M |
| Interest Expense | $14.77M | $14.77M | $13.06M | $7.96M | $5.92M |
| Tax Expense | $0.00 | $724.00K | $39.00K | -$33.00K | $137.00K |
| Net Income | -$94.66M | -$45.62M | -$46.80M | -$53.34M | -$40.54M |
| EPS (basic) | -0.2500 | -0.1400 | -0.1400 | -0.1600 | -0.1200 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |